Iron deficiency anemia is diagnosed through a combination of blood tests, starting with a complete blood count and followed by iron-specific lab work. A hemoglobin level below 12 g/dL in women or below 13.6 g/dL in men confirms anemia, and additional markers like ferritin and transferrin saturation pinpoint whether low iron is the cause. The process is straightforward but sometimes requires several rounds of testing, especially when other conditions complicate the picture.
The Complete Blood Count Comes First
The initial test for any suspected anemia is a complete blood count, or CBC. This single blood draw measures your hemoglobin (the oxygen-carrying protein in red blood cells), your red blood cell count, and several values describing the size and color of those cells. Two of these values matter most for iron deficiency: MCV, which measures red blood cell size, and MCHC, which reflects how much hemoglobin is packed into each cell.
In iron deficiency anemia, your body can’t produce enough hemoglobin, so it compensates by making smaller red blood cells. An MCV below 80 fL signals these undersized cells, a pattern called microcytic anemia. The MCHC also drops below 30%, meaning each cell looks paler than normal under a microscope. This combination of small, pale red blood cells is the hallmark CBC pattern for iron deficiency. However, the same pattern can show up in thalassemia (a genetic hemoglobin disorder), so the CBC alone doesn’t seal the diagnosis.
Iron Studies Confirm the Cause
Once the CBC suggests iron deficiency, the next step is a panel of iron-specific blood tests. These typically include serum ferritin, serum iron, total iron-binding capacity (TIBC), and transferrin saturation. Together, they paint a detailed picture of your body’s iron stores and how well iron is being transported through your bloodstream.
Ferritin is the single most useful marker. It reflects how much iron your body has in reserve. The World Health Organization has traditionally used a threshold of 15 ng/mL or lower to define iron deficiency, but the American Gastroenterological Association now recommends a more liberal cutoff of 45 ng/mL or lower. This higher threshold catches more cases, particularly in people whose ferritin is artificially elevated by inflammation, infection, or liver disease. If your ferritin is below 30 ng/mL and you have symptoms, iron deficiency is highly likely.
Transferrin saturation tells you what percentage of your blood’s iron-transport protein is actually carrying iron. Normal ranges sit between 20% and 50% for men and 15% and 45% for women. A transferrin saturation below 20% strongly supports iron deficiency. TIBC, which measures how much capacity your blood has to bind iron, tends to rise when iron stores are low, as your body ramps up production of transport proteins to scavenge whatever iron is available.
When Ferritin Is Hard to Interpret
Ferritin is an acute-phase reactant, meaning it rises during inflammation regardless of your actual iron levels. This creates a diagnostic blind spot for people with chronic inflammatory conditions like rheumatoid arthritis, inflammatory bowel disease, kidney disease, or active infections. In these cases, ferritin might read as normal or even high while your body is genuinely iron-depleted.
A test called soluble transferrin receptor (sTfR) can help cut through this confusion. Unlike ferritin, sTfR levels aren’t affected by inflammation. When your tissues are starved for iron, sTfR rises because cells produce more receptors trying to grab whatever iron they can. Elevated sTfR levels (above 5.0 mg/L for men, above 4.0 mg/L for women) point toward true iron deficiency even when inflammatory markers are high. Clinicians sometimes calculate an sTfR index by dividing sTfR by a log-transformed ferritin value. An index of 3.2 or higher suggests iron deficiency anemia, while values below 2 point toward anemia of chronic disease without iron depletion.
Distinguishing Iron Deficiency From Thalassemia
Both iron deficiency and beta-thalassemia trait produce small red blood cells on a CBC, so they can look nearly identical at first glance. The difference lies in what the bone marrow is doing. In iron deficiency, the marrow produces fewer red blood cells overall because it lacks the raw material. In thalassemia, the marrow produces a normal or even elevated number of red blood cells, but each one is abnormally small due to a genetic defect in hemoglobin production.
A quick screening tool called the Mentzer index helps sort this out. You divide the MCV by the red blood cell count. A result above 13 favors iron deficiency anemia. A result below 13 suggests thalassemia trait. This isn’t definitive on its own, but it’s a useful first step that can guide whether you need genetic testing (for thalassemia) or iron studies (for deficiency). In many cases, both conditions can coexist, particularly during pregnancy.
Physical Signs Your Doctor May Check
Blood tests do the heavy lifting, but a physical exam can offer supporting clues. Pale skin, especially noticeable inside the lower eyelids and on the nail beds, is one of the earliest visible signs. More specific to iron deficiency are brittle or spoon-shaped nails (where the nail curves upward at the edges like a shallow spoon), a sore or swollen tongue, and cracks at the corners of the mouth. These findings don’t appear in every case and tend to develop only after iron stores have been depleted for a significant period.
Diagnosis During Pregnancy
Pregnancy changes the diagnostic thresholds because blood volume expands naturally, diluting hemoglobin levels. The standard cutoffs are a hemoglobin below 11 g/dL in the first and third trimesters and below 10.5 g/dL in the second trimester, when blood dilution peaks.
Ferritin thresholds also shift. A ferritin level below 30 ng/mL during pregnancy is enough to warrant treatment, even before hemoglobin drops into the anemic range. This lower bar reflects how quickly a pregnant person can become anemic once iron stores run low, given the demands of a growing fetus and expanding blood supply. Screening typically happens at the first prenatal visit and again in the late second or early third trimester.
Screening in Infants and Children
Children are screened differently because their hemoglobin norms vary by age. The WHO defines anemia as hemoglobin below 10.5 g/dL for ages 6 to 23 months, below 11 g/dL for ages 2 to 5, and below 11.5 g/dL for ages 5 to 11. Ferritin cutoffs are also lower: below 12 ng/mL for children under 5, and below 15 ng/mL for older children and adolescents.
Current consensus guidelines recommend a first screening between 9 and 12 months of age, with annual checks from ages 1 through 5. Children at higher risk, such as those born preterm, exclusively breastfed without iron supplementation, or with restricted diets, may be screened as early as 6 months.
Finding the Underlying Cause
Confirming iron deficiency anemia is only half the diagnostic process. The other half is figuring out why you’re iron deficient in the first place. In premenopausal women, heavy menstrual bleeding is the most common explanation. In men and postmenopausal women, the concern shifts to gastrointestinal blood loss, which can be slow, invisible, and caused by anything from ulcers to polyps to colorectal cancer.
Guidelines from both the British Society of Gastroenterology and the American Gastroenterological Association recommend that men and postmenopausal women with iron deficiency anemia undergo both upper and lower endoscopy to examine the digestive tract for sources of bleeding. These procedures remain the gold standard. For patients where endoscopy carries significant risk (due to age or other medical conditions), fecal occult blood testing can help stratify who is most likely to benefit from the invasive workup. A negative fecal occult blood test can help screen out lower-risk patients, though it doesn’t replace endoscopy for the majority of cases.
In younger women, dietary intake and menstrual history are evaluated first. Celiac disease, which impairs iron absorption in the small intestine, is another commonly investigated cause across all age groups and can be checked with a simple blood antibody test.